Outcome of the Board Meeting held on May 24, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Board approved audited financial results for Q4 and FY ended March 31, 2025, along with appointment of M/s. Rajesh Dudhara & Co. as Internal Auditor for FY 2025-26. Statutory auditor R. K. Doshi & Co. LLP issued an unmodified (unqualified) opinion. FY25 revenue from operations rose to ₹9,030.60 Lakhs from ₹7,520.81 Lakhs (about 20% growth), but profit before exceptional items and tax dipped slightly to ₹1,012.31 Lakhs vs ₹1,151.18 Lakhs. Net profit surged to ₹2,399.62 Lakhs (vs ₹838.56 Lakhs) mainly due to a one-time gain of ₹2,334.82 Lakhs from sale of property, plant and equipment, partially offset by a ₹402.97 Lakhs write-off related to a cyber fraud. EPS rose to ₹106.73 from ₹37.40. Operating cash flow was negative at ₹(97.43) Lakhs, though investing activities turned strongly positive due to the PPE sale.
Core operating performance was largely flat with a slight dip in pre-exceptional profits, and the headline PAT jump is largely driven by a one-time asset sale. The cyber fraud write-off of ₹402.97 Lakhs is a negative governance signal. Negative operating cash flow despite higher revenue suggests working capital strain, though the asset sale has strengthened the balance sheet with other equity rising to ₹4,506.41 Lakhs.